Novo Nordisk AS NVO, once the darling of the pharmaceutical world, tumbled Monday as investors reacted to what analysts are calling a “worst-case scenario.” Shares of Novo Nordisk stock plunged over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results